Our undergraduate grant assists students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. The time commitment required for assisting with lab-directed research or for working on an independent undergraduate thesis project often presents a financial burden to the undergraduate student. CABRI’s undergraduate grant can be utilized as a stipend for the student and as funds for supplies. Grants range from $2,000 – $5,000 and may be awarded as individual or group grants.
Undergraduate Applications will be accepted from August 12 – October 6, 2019 (11:59 pm EDT). Applications received outside of this time frame will not be considered.
Awards will be announced October 18, 2019.
As part of our commitment to the families of individuals suffering with rare diseases, CABRI provides scholarships to college-bound students who have lost a parent to SNUC, Mastocytosis or Ichthyosis.
Criteria for eligibility:
- Have a parent deceased as a result of SNUC, Mastocytosis or Ichthyosis
- Have a demonstrated need for financial assistance
- Have been accepted to attend a two- or four-year accredited college or technical school
The scholarships are awarded annually based on need and availability of funds. All awards are given to the recipient for payment of tuition, fees, and other required expenses.
Mackenzie Sederburg will be receiving the SNUC Scholarship for the 2019/2020 school year!
Mackenzie is an Exercise Science major and Psychology minor at Wayne State University. She is excited to continue her education and obtain her doctorate in Occupational Therapy. Her passion for OT stemmed from witnessing her father’s OT appointments when he was undergoing SNUC treatment during her youth. Throughout her college career, Mackenzie has made her mark through participation in many organizations: Wayne State College Pre-PT/OT Club, Vice President of the Psi Chi International Honors Society in psychology, and the Love Your Melon organization supporting juvenile cancer funding. Congrats, Mackenzie!
CABRI is fully dedicated to actively researching new treatments for rare diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development of our mission.
Eligible applicants include domestic and international researchers alike, as well as domestic and international group collaborations. Research grants are open to investigators of any career stage who are capable of leading an independent research study and supervising personnel. Funds must be used solely for research. CABRI does not fund excessive institutional overhead costs.
Applications may be submitted at any time during the year.
To apply for a CABRI research grant, please use our Research Proposal Application.
2019 Grant Recipients
$50,000 – Dr. Stefan Zwingenberger, University of Dresden Research entitled: “Enhancement of bone regeneration by functionalization of various bone substitution materials with a novel and potent lactam acetylene EP4 receptor agonist (KMN-159).”
2018 Grant Recipients
$50,000 – Dr. Sven-Erik Dahlen, Karolinska Institute Research entitled: “Inhibition of prostaglandin D2 biosynthesis: an unmet need in many inadequately treated diseases.”
$50,000 – Michael Holinstadt, University of Michigan Research entitled: “Assessing whether 12-LOX deficiency reduces incidences of thrombocytopenia.”
2017 Grant Recipients
$59,200 – Dr. Peter Krieg, DKFZ, Research entitled: ““Novel therapeutic approached for the treatment of autosomal recessive congenital ichthyoses (ARCI).”
$17,000 – Dr. Stefan Zwingenberger, University of Dresden Research entitled: “Enhancement of bone regeneration by functionalization of various bone substitution materials with a novel and potent lactam acetylene EP4 receptor agonist (KMN-159).”
2016 Grant Recipients
$50,000 – Migual Gijon, University of Colorado-Denver Research entitled: “Lipid mediators in urine as indicators of ongoing inflammation and progression of disease when mice are injected with maresin 1 into the peritoneal cavity.”
2015 Grant Recipients
$59,200 – Dr. Peter Krieg, DKFZ Research entitled: “Novel therapeutic approach for the treatment of autosomal recessive congenital ichthyoses (ARCI).”